Belvedere Trading’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Hold
0
187
2024
Q1
Sell
-13,213
Closed -$194K 198
2023
Q4
$194K Buy
+13,213
New +$194K ﹤0.01% 95
2023
Q1
Sell
-7,642
Closed -$282K 255
2022
Q4
$282K Sell
7,642
-35,857
-82% -$1.32M ﹤0.01% 64
2022
Q3
$1.63M Sell
43,499
-125,089
-74% -$4.68M 0.05% 10
2022
Q2
$3.52M Buy
+168,588
New +$3.52M 0.11% 7